Cesca Therapeutics adds Mark Bagnall to board
Mr. Bagnall has more than 20 years of experience in senior management positions in both public and private biotechnology companies. He is the Co-Founder of Naia Pharmaceuticals where he currently serves as Director, Chief Financial Officer and Chief Operating Officer.
Mr. Bagnall serves as Chairman of the Board of XCR Diagnostics and as a director on the Board of Directors of Ativa Medical. ■